Cargando…
A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma
We report a case of severe type B lactic acidosis (LA) in a 51-year-old male, 12 days after he received his first dose of nivolumab for metastatic Von Hippel Lindau (VHL)-mutated, clear cell renal cell carcinoma. Throughout his hospital course, infection, hypoperfusion, and tissue necrosis were not...
Autores principales: | Nakajima, Erica, Leger, Paul, Mayer, Ingrid A., Neuss, Michael N., Chism, David D., Rathmell, W. Kimryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179105/ https://www.ncbi.nlm.nih.gov/pubmed/30334008 http://dx.doi.org/10.3233/KCA-160004 |
Ejemplares similares
-
VHL Type 2B Mutations Retain VBC Complex Form and Function
por: Hacker, Kathryn E., et al.
Publicado: (2008) -
Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response
por: DeSimone, Michelle C., et al.
Publicado: (2013) -
Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012) -
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
por: Monti, Matilde, et al.
Publicado: (2020) -
Hemodialysis for Lactic Acidosis
por: Karthiraj, N., et al.
Publicado: (2017)